Innoviva, Inc. is engaged in the development, commercialization, and financial management of biopharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate, and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Burlingame, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
127
Frequently Asked Questions
What is Market Cap of Innoviva Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Innoviva Inc market cap is $1.19B.
What is the 52-week high for Innoviva Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Innoviva Inc 52 week high is $22.00 as of September 29, 2025.
What is the 52-week low for Innoviva Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Innoviva Inc 52 week low is $16.67 as of September 29, 2025.
What is Innoviva Inc stock price today?
Innoviva Inc stock price today is $19.03.
What was Innoviva Inc stock price yesterday?
Innoviva Inc stock price yesterday was $18.86.
What is the PE ratio of Innoviva Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Innoviva Inc’s P/E ratio is 56.84.
What is the Price-to-Book ratio of Innoviva Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Innoviva Inc P/B ratio is 1.6625.
What is the 50-day moving average of Innoviva Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Innoviva Inc 50-day moving average is $19.55.
